中文摘要 |
為瞭解市售消渴類中藥製劑如加減玉泉丸、三消治尿九、愈渴丸、三多散、清肝解毒丸及黃連解毒丸等,是否摻加西藥及其微生物污染情形,在民國73年11月至74年1月間前往台灣省、台北市、高雄市等各地區抽購檢體計100件。以薄層層析法鑑別是否加西藥成分[薄層板:Silica gel 60 Fask;Plastic展開溶媒:(1)Benzene:Acetone(4:1),(2)Toluene:Chloroform:Glacial Acetic Acid:Water(20:20:10:0.5),檢出方法:(1)UV light,(2)1% Vanillin-H2SO4 Solution,3 p-Dimethy laminoberaldehyde T. S.]。並依中華藥典第三版,藥典第廿版之需氧微生物總數測定方法:(种取檢體10g,必要時予以研磨成粉狀,加入pH 7.2磷酸緩衝液調配為100ml,然後做10倍連續稀釋。各稀釋液用平板2個試驗,每個平板加入其稀釋液1ml,然後傾注約45°C Soybean Casein Digest Agar Medium 15~20 ml,在35°C培養48小時,計算其總活菌數)進行該類製劑之微生物污染試驗。世界衛生組織(WHO)在一般製劑微生物容許量」中,對於生藥製劑菌數限度並無明文規定,而目前我國對生藥製劑之微生物限度亦尚無國家標準。若依照WHO一般製劑微生物容許量之標準,即每g生菌數需在1000個以下,則此次檢體100件中超過此限度有87件。
For the investigation on drug adulteration and microbial contamination in Chinese medicine preparation for diabetes, 100 samples were random by collected in Taiwan area from Nov. 1984 to Jan. 1985. The results of thin layer chromatography analysis showed none of the samples was adulterated with acetohexamide, chloropropamide, glibenclamide, tolbutamide, sulfadiazine, sulfadimethoxine, sulfamerazine, sulfamethazine, sulfamethoxazole, sulfathiazole, sulfisoxazole and sulfamethoxypyridazine. But the microbial test indicated wost of the samples were highly contaminated. |